• Product NameRaltegravir potassium
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityRaltegravir potassium salt(MK0518 potassium salt) is a potent integrase (IN) inhibitor, used to treat HIV infection.
• Target NameHIV Protease inhibitor; Integrase inhibitor
• CAS No. 871038-72-1
• Calculated MW 482.51
• Formulation C20H20FN6O5K
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1
  Pathways:Microbiology&virology; Proteases/Proteasome
  Receptor:HIV; Integrase (IN)
  Boling pt:
  Melting pt:282C
  Solubility:Soluble in DMSO
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Hare, S., et al. Proc Natl Acad Sci U S A, 2010. 107(46): p. 20057-62.2. Lewis M.G., et al. Retrovirology, 2010. 7: p. 21.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting